World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
71
Citations
32259
World Ranking
19924
National Ranking
9922

Overview

Robert E. Ratner is affiliated with Georgetown University in the United States. Their research primarily focuses on medicine, with particular attention to physiology, endocrinology, diabetes and metabolism, surgery, molecular biology, and cardiology and cardiovascular medicine.

The scientist has contributed to multiple topics within these fields, including:

  • Diet and metabolism studies
  • Metabolism, Diabetes, and Cancer
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • COVID-19 and Mental Health
  • Diabetes and associated disorders

Their publication record shows involvement in several recent papers such as:

  • COVID-19 in People With Diabetes: Urgently Needed Lessons From Early Reports, 2020, Diabetes Care
  • Metformin Should Be Used to Treat Prediabetes in Selected Individuals, 2020, Diabetes Care
  • Illnesses associated with ketosis including diabetic ketoacidosis during very low carbohydrate and ketogenic diets, 2025, Diabetes Obesity and Metabolism
  • 307-OR: Mean Blood Beta-Hydroxybutyrate Predicts Clinically Significant Weight Loss following 90 Days Carbohydrate-Restricted Nutrition Therapy, 2021, Diabetes
  • Sustained metabolic improvements in a remotely delivered ketogenic nutrition programme for veterans with type 2 diabetes: A 3-year observational study, 2025, Diabetes Obesity and Metabolism

Frequent publication venues for Robert E. Ratner include:

  • Diabetes Care
  • Diabetes Obesity and Metabolism
  • Diabetes
  • Frontiers in Public Health
  • Journal of clinical lipidology

Collaborative work is a notable aspect of their research, with frequent co-authors including:

  • Shaminie J. Athinarayanan
  • Amy L. McKenzie
  • Rebecca N. Adams
  • Stephen D. Phinney
  • Brittanie M. Volk

Best Publications

  • Diabetic Kidney Disease: A Report From an ADA Consensus Conference

    Katherine R. Tuttle;George L. Bakris;Rudolf W. Bilous;Jane L. Chiang

  • Effects of Exenatide (Exendin-4) on Glycemic Control and Weight Over 30 Weeks in Metformin-Treated Patients With Type 2 Diabetes

    Ralph A. DeFronzo;Robert E. Ratner;Jenny Han;Dennis D. Kim

  • Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial.

    Alan Garber;Robert Henry;Robert Ratner;Pedro A Garcia-Hernandez

  • The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial.

    Trevor J. Orchard;Marinella Temprosa;Ronald Goldberg;Steven Haffner

  • Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association.

    Richard A. Insel;Jessica L. Dunne;Mark A. Atkinson;Jane L. Chiang

  • Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study.

    Frans J Th Wackers;Lawrence H Young;Silvio E Inzucchi;Deborah A Chyun

  • Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations

    Francesco Rubino;David M. Nathan;Robert H. Eckel;Philip R. Schauer

  • Prevention of Diabetes in Women with a History of Gestational Diabetes: Effects of Metformin and Lifestyle Interventions

    Robert E. Ratner;Costas A. Christophi;Boyd E. Metzger;Dana Dabelea

  • Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial.

    Lawrence H. Young;Frans J. Th. Wackers;Deborah A. Chyun;Janice A. Davey

  • Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis

    Jay S. Skyler;George L. Bakris;Ezio Bonifacio;Tamara Darsow

  • The Diabetes Prevention Program: Design and methods for a clinical trial in the prevention of type 2 diabetes

    G. A. Bray;K. S. Polonsky;P. G. Watson;R. B. Goldberg

  • Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance

    Ralph A. DeFronzo;Devjit Tripathy;Dawn C. Schwenke;Dawn C. Schwenke;Mary Ann Banerji

  • The Cost-Effectiveness of Lifestyle Modification or Metformin in Preventing Type 2 Diabetes in Adults with Impaired Glucose Tolerance

    William H. Herman;Thomas J. Hoerger;Michael Brandle;Katherine Hicks

  • Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.

    Robert Ratner;Ronald Goldberg;Steven Haffner;Santica Marcovina

  • Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes

    Thomas J. Hoerger;Albert D. Bethke;Anke Richter;Stephen W. Sorensen

  • Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999-2002: the National Health and Nutrition Examination Survey.

    Helaine E. Resnick;Gregory L. Foster;Joan Bardsley;Robert E. Ratner

  • Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.

    Robert E. Ratner;Irl B. Hirsch;James L. Neifing;Satish K. Garg

  • Randomized Trial of an Inhibitor of Formation of Advanced Glycation End Products in Diabetic Nephropathy

    W. Kline Bolton;Daniel C. Cattran;Mark E. Williams;Sharon G. Adler

  • The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: An intent-to-treat analysis of the DPP/DPPOS

    W. H. Herman;S. L. Edelstein;R. E. Ratner;Maria G Montez

  • Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program.

    William H Hernan;Michael Brandle;Ping Zhang;David F Williamson

Frequent Co-Authors

Trevor J. Orchard
Trevor J. Orchard University of Pittsburgh
Ralph A. DeFronzo
Ralph A. DeFronzo The University of Texas Health Science Center at San Antonio
Robert R. Henry
Robert R. Henry University of California, San Diego
Sunder Mudaliar
Sunder Mudaliar University of California, San Diego
Thomas A. Buchanan
Thomas A. Buchanan University of Southern California
Abbas E. Kitabchi
Abbas E. Kitabchi University of Tennessee Health Science Center
George A. Bray
George A. Bray Louisiana State University
William H. Herman
William H. Herman University of Michigan–Ann Arbor
Silvio E. Inzucchi
Silvio E. Inzucchi Yale University
Barbara V. Howard
Barbara V. Howard MedStar Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA can also lead to a variety of related healthcare careers, many of which offer online degree options and flexible pathways for students at different stages.

For those looking to become a nurse without the barrier of standardized entrance exams, consider enrolling in an lpn school without teas test. This option provides a smoother entry point for aspiring nurses.

Interested in healthcare leadership? A degree in healthcare administration can open doors to managerial roles in hospitals and clinics, often through rigorous but accessible online programs.

Registered nurses seeking career advancement can explore asn to fnp programs, which are designed as bridge programs to help RNs progress smoothly towards becoming Family Nurse Practitioners.

Lastly, those passionate about health and wellness may consider one of the best online nutrition programs. These degrees provide foundations for careers in dietetics and health education.

Best Scientists Citing Robert E. Ratner

Trending Scientists

Recently Published Articles